Rationale for contemporary antimicrobial treatment of Stenotrophomonas maltophilia: a narrative review
Background: Stenotrophomonas maltophilia is an opportunistic pathogen most commonly isolated from patients with complex/life-threatening disease or cystic fibrosis. Traditionally, when treatment is warranted, trimethoprim-sulfamethoxazole has been the agent of choice, alone or in combination with a...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-06-01
|
| Serie: | CMI Communications |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S295059092500023X |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|